FDA: Recalled catheters pose serious safety risk; compounded drug recalled

Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker bands to move or dislodge during procedures. The Food and Drug Administration has identified this as a Class I recall due to the potential for serious injury or death.
In other news, IntegraDose Compounding Services this week recalled certain lots of Cefazolin for injection, an intravenous antibiotic, due to a lack of sterility assurance. The lots were recently distributed to U.S. hospitals, which should immediately quarantine the product for return to the company.
Related News Articles
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…
Blog
During World War II, the U.S. Army Air Corps depended on its B-17 bombers to inflict incredible damage against the Axis powers in Europe. These “Flying…
Headline
The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine…
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage Embolization Devices due to reports…
Headline
The Food and Drug Administration March 5 announced that Baxter Healthcare Corporation recalled its Spectrum infusion pumps due to the potential for missing…